文献速递甲状腺与浅表头颈US

美国放射学会甲状腺影像报告与数据系统减少甲状腺结节活检并提高准确性

Reduction in Thyroid Nodule Biopsies and Improved Accuracy with American College of Radiology Thyroid Imaging Reporting and Data System.
PubMed 文献 · Radiology · 2018-03-02

本回顾性研究由8名放射科医生对100个甲状腺结节评估超声特征并按自身习惯给出活检建议,再回顾性应用ACR TI-RADS标准生成建议。应用后平均建议活检结节数从80±16降至57±11,特异度从20%升至44%、准确率从28%升至52%,敏感度从95%降至92%。作者结论认为ACR TI-RADS标准可显著减少活检数量并提高管理建议准确性。

要点

  • 应用ACR TI-RADS后平均建议活检结节数由80±16个降至57±11个。
  • 应用ACR TI-RADS后特异度由20%升至44%、准确率由28%升至52%。
  • 应用ACR TI-RADS后敏感度由95%降至92%,多数恶性结节仍符合超声随访标准。

核心结论

  • ACR TI-RADS标准可显著减少建议活检的甲状腺结节数量,并显著提高结节管理建议的准确性。

研究设计与样本

  • 回顾性研究,8名有3-32年甲状腺超声经验的放射科医生复习2016年12月100个经细胞学证实、病理证实或两者兼有的甲状腺结节的超声特征,另有3名专家放射科医生作为影像所见参考标准读者。

关键影像表现/征象

  • 放射科医生在5个超声类别上评估结节特征,并在不知晓ACR TI-RADS标准的情况下按自身实践模式给出活检建议。
  • 100个结节中15个(15%)为恶性。
  • 应用ACR TI-RADS标准后,多数未建议活检的恶性结节符合超声随访标准,仅120次恶性结节 encounters 中的3次(2.5%)无需随访或活检。

诊断标准与关键数值

  • 未使用ACR TI-RADS时,读者总体敏感度95%(95%CI:83%,99%)、特异度20%(95%CI:16%,25%)、准确率28%(95%CI:21%,37%)。
  • 应用ACR TI-RADS后,总体敏感度92%(95%CI:68%,98%)、特异度44%(95%CI:33%,56%)、准确率52%(95%CI:40%,63%)。
  • 专家共识按ACR TI-RADS标准建议对100个结节中的55个进行活检,其敏感度87%(95%CI:48%,98%)、特异度51%(95%CI:40%,62%)、准确率56%(95%CI:46%,66%)。

临床应用与阅片要点

  • 原文结论认为ACR TI-RADS标准可显著减少建议活检的甲状腺结节数量并提高管理建议准确性。
  • 按自身实践模式,8名放射科医生平均建议活检80±16个结节(范围38-95个);回顾性应用ACR TI-RADS标准后平均为57±11个(范围37-73个)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare the biopsy rate and diagnostic accuracy before and after applying the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) criteria for thyroid nodule evaluation. Materials and Methods In this retrospective study, eight radiologists with 3-32 years experience in thyroid ultrasonography (US) reviewed US features of 100 thyroid nodules that were cytologically proven, pathologically proven, or both in December 2016. The radiologists evaluated nodule features in five US categories and provided biopsy recommendations based on their own practice patterns without knowledge of ACR TI-RADS criteria. Another three expert radiologists served as the reference standard readers for the imaging findings. ACR TI-RADS criteria were retrospectively applied to the features assigned by the eight radiologists to produce biopsy recommendations. Comparison was made for biopsy rate, sensitivity, specificity, and accuracy. Results Fifteen of the 100 nodules (15%) were malignant. The mean number of nodules recommended for biopsy by the eight radiologists was 80 ± 16 (standard deviation) (range, 38-95 nodules) based on their own practice patterns and 57 ± 11 (range, 37-73 nodules) with retrospective application of ACR TI-RADS criteria. Without ACR TI-RADS criteria, readers had an overall sensitivity, specificity, and accuracy of 95% (95% confidence interval [CI]: 83%, 99%), 20% (95% CI: 16%, 25%), and 28% (95% CI: 21%, 37%), respectively. After applying ACR TI-RADS criteria, overall sensitivity, specificity, and accuracy were 92% (95% CI: 68%, 98%), 44% (95% CI: 33%, 56%), and 52% (95% CI: 40%, 63%), respectively. Although fewer malignancies were recommended for biopsy with ACR TI-RADS criteria, the majority met the criteria for follow-up US, with only three of 120 (2.5%) malignancy encounters requiring no follow-up or biopsy. Expert consensus recommended biopsy in 55 of 100 nodules with ACR TI-RADS criteria. Their sensitivity, specificity, and accuracy were 87% (95% CI: 48%, 98%), 51% (95% CI: 40%, 62%), and 56% (95% CI: 46%, 66%), respectively. Conclusion ACR TI-RADS criteria offer a meaningful reduction in the number of thyroid nodules recommended for biopsy and significantly improve the accuracy of recommendations for nodule management. © RSNA, 2018 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Hoang JK, Middleton WD, Farjat AE, et al. Reduction in Thyroid Nodule Biopsies and Improved Accuracy with American College of Radiology Thyroid Imaging Reporting and Data System. Radiology. 2018. PMID: 29498593. doi:10.1148/radiol.2018172572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。